Pending final negotiation, grant will fund up to 20 patients in the OCTOPOD-IV Phase 2a expansion study of THEO-260 in platinum-resistant ovarian cancerCompetitive funding award highlights Theolytics’ ...

ASHBURN, VA - March 05, 2026 - PRESSADVANTAGE - GBC Kitchen and Bath, a premier remodeling contractor serving Northern ...

Guidance for FY '27 is slightly lower than the previous year's growth rate, with management embedding continued PLG and tech sector headwinds into the outlook, whereas in Q3, management cited ...

BrYet US, Inc. (“BrYet”) — a biotechnology innovator focused on developing curative therapies for advanced cancers — announced today that it has ...

BNY Mellon Small/Mid Cap Growth Fund (Class A shares at NAV) outperformed its benchmark, the Russell 2500 Growth Index, ...

Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) Q4 2025 Earnings Call Transcript March 5, 2026 Atea Pharmaceuticals, Inc. misses on ...

Vertiv (VRT) stock fell 3.1% Friday on high volume despite beating Q4 earnings estimates. Analysts upgraded targets to $290 ...

The American Club has reported a broadly positive outcome from its 2026 renewal, posting growth in tonnage and premium, ...

Webull Corporation Class A Ordinary Shares (NASDAQ:BULL) Q4 2025 Earnings Call Transcript March 5, 2026 Operator: Good afternoon, and welcome to the Webull Corporation Fourth Quarter and Full Year ...

(NASDAQ: MKTW) (“MarketWise” or the “Company”), a leading multi-brand digital subscription services platform that provides premium financial research, software, education, and tools for self-directed ...

Tuya Inc. ("Tuya" or the "Company") (NYSE: TUYA; HKEX: 2391), a global leading AI cloud platform service provider, today announced its unaudited financial results for the fourth quarter and fiscal ...

First glucokinase-activator (GKA) approval outside mainland China Approval supports a differentiated approach to Type 2 diabetes (T2D) management Hong Kong will serve as Hua Medicine's launchpad for ...